BROKERS CHOICE: AARTIIND, IDFCFIRST, FORTIS, LIC, AUROPHARMA, NMDC, INFOEDGE, HAL, BEL, BEML, INDUSIND, RIL, JIOFINA, IREDA

MUMBAI, 28 MAY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

UBS on Aarti Ind: Upgrade to Buy on Company, raise target price at Rs 625 versus Rs 615 (Positive)

Nomura on Fortis: Maintain Buy on Company, raise target price at Rs 820 versus Rs 700 (Positive)

JP Morgan on IDFC First: Upgrade to Neutral on Company, raise target price at Rs 63 (Positive)

Macquarie on LIC: Maintain Outperform on Company, target price at Rs 1215 (Positive)

CLSA on Auro Pharma: Maintain Outperform on Company, target price at 1400 (Positive)

GS on Auro Pharma: Maintain Buy on Company, target price at Rs 1275 (Positive)

JP Morgan on NMDC: Maintain Underweight on Company, target price at Rs 56 (Neutral)

Citi on Info Edge: Maintain Buy on Company, cut target price at Rs 1685 (Neutral)

Nomura on Info Edge: Maintain Buy on Company, cut target price at Rs 1670 (Neutral)

GS on LIC: Maintain Neutral on Company, target price at Rs 880/ (Neutral)

MOSL on LIC: Maintain Buy on Company, target price at Rs 1050/ (Neutral)

UBS on Auro Pharma: Maintain Sell on Company, target price at Rs 1200 (Neutral)

Citi on Auro Pharma: Maintain Sell on Company, target price at Rs 1100 (Neutral)

CLSA on TTK Prestige: Maintain Hold on Company, cut target price at Rs 620 (Neutral)

Jefferies on Afcons: Maintain Buy on Company, target price at Rs 580 (Neutral)

Nomura on KEC Int: Maintain Buy on Company, target price at Rs 985 (Neutral)

JP Morgan on Indusind Bank: Downgrade to Reduce on Bank, cut target price at Rs 660 versus Rs 770 (Negative)

JP Morgan on Federal Bank: Downgrade to Neutral on Bank, target price at Rs 210 (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)